System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Systematic Review Journal Article Epublish 12 citations

PubMed: 37864272 DOI: 10.1186/s12974-023-02911-w

A systematic review of immune-based interventions for perinatal neuroprotection: closing the gap between animal studies and human trials.

J Neuroinflammation 20(1):241

Authors: Sharmony B Kelly, Nhi T Tran, Graeme R Polglase, Rodney W Hunt, Marcel F Nold, Claudia A Nold-Petry, David M Olson, Sylvain Chemtob, Gregory A Lodygensky, Sarah A Robertson, Alistair J Gunn, Robert Galinsky

Affiliations

  • The Ritchie Centre, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, Melbourne, VIC, 3168, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.
  • Department of Paediatrics, Monash University, Melbourne, VIC, Australia.
  • Monash Newborn, Monash Children's Hospital, Melbourne, Australia.
  • Department of Obstetrics and Gynaecology, University of Alberta, Edmonton, Canada.
  • Department of Paediatrics, CHU Sainte Justine Research Centre, University of Montreal, Quebec, Canada.
  • The University of Adelaide, Robinson Research Institute, North Adelaide, SA, Australia.
  • Department of Physiology, The University of Auckland, Auckland, New Zealand.
  • The Ritchie Centre, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, Melbourne, VIC, 3168, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.

Abstract

BACKGROUND

Perinatal infection/inflammation is associated with a high risk for neurological injury and neurodevelopmental impairment after birth. Despite a growing preclinical evidence base, anti-inflammatory interventions have not been established in clinical practice, partly because of the range of potential targets. We therefore systematically reviewed preclinical studies of immunomodulation to improve neurological outcomes in the perinatal brain and assessed their therapeutic potential.

METHODS

We reviewed relevant studies published from January 2012 to July 2023 using PubMed, Medline (OvidSP) and EMBASE databases. Studies were assessed for risk of bias using the SYRCLE risk of bias assessment tool (PROSPERO; registration number CRD42023395690).

RESULTS

Forty preclinical publications using 12 models of perinatal neuroinflammation were identified and divided into 59 individual studies. Twenty-seven anti-inflammatory agents in 19 categories were investigated. Forty-five (76%) of 59 studies reported neuroprotection, from all 19 categories of therapeutics. Notably, 10/10 (100%) studies investigating anti-interleukin (IL)-1 therapies reported improved outcome, whereas half of the studies using corticosteroids (5/10; 50%) reported no improvement or worse outcomes with treatment. Most studies (49/59, 83%) did not control core body temperature (a known potential confounder), and 25 of 59 studies (42%) did not report the sex of subjects. Many studies did not clearly state whether they controlled for potential study bias.

CONCLUSION

Anti-inflammatory therapies are promising candidates for treatment or even prevention of perinatal brain injury. Our analysis highlights key knowledge gaps and opportunities to improve preclinical study design that must be addressed to support clinical translation.

MeSH

Bias, Brain, Neuroprotection, Therapeutics

Cited by